The proposed sale is small relative to market cap and appears to be a routine diversification move by a director. Monitor whether the sale actually executes and if other insiders follow with similar filings.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $90.95entry
- T+1 · 6d ago +1.17%α −0.15% · $92.01
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director James R. Tobin filed a Form 144 notice of intent to sell 4,059 shares of TransMedics Group, Inc. common stock, with an estimated aggregate market value of approximately $385,468 based on the filing date. The shares were acquired through restricted stock grants in 2024, 2025, and 2026, and the sale is planned for or around November 9, 2026.
Key Facts
- James R. Tobin, a director of TransMedics Group, Inc., filed a Form 144 on November 9, 2026.
- The proposed sale involves 4,059 shares of common stock.
- Estimated aggregate market value of the proposed sale is approximately $385,468.
- Shares were acquired via restricted stock grants on May 23, 2024 (1,193 shares), May 22, 2025 (732 shares), and May 20, 2026 (2,134 shares).
- The sale is intended to be executed through Morgan Stanley Smith Barney LLC.
Financial Impact
Proposed sale of 4,059 shares valued at ~$385,468, representing a small fraction of the company's $2.4B market cap (approximately 0.016%).
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- No information on the director's remaining holdings, so the proportional impact on his personal position is unknown.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010898 |
| Document: 0001950047-26-010898-index.html | 0001950047-26-010898 |
| Document: 0001950047-26-010898.txt | 0001950047-26-010898 |
Track record
9 reports on TMDX
3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +22.27% at T+60 after the Jun 11, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $90.95 Now $92.21 +1.39% settles Nov 17
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $88.24 to $91.38 Now $92.21 +4.50% ▲ +3.56% +0.96% vs SPY
- Nov 5, 202611d ago Press Release Bullish 6/10 No price data
- Jun 12, 202622w ago Institutional Cluster Bullish 6/10 Entry $72.91 to $78.79 Now $92.21 +26.47% ▲ +8.06% +7.39% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $73.59 to $73.22 Now $92.21 +25.30% ▼ −0.50% −0.94% vs SPY
- Apr 10, 202631w ago DEFA14A Neutral 3/10 Entry $114.00 to $115.87 Now $92.21 −19.11% ▲ +1.64% −2.86% vs SPY
- Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $147.00 to $134.77 Now $92.21 −37.27% ▼ −8.32% −7.11% vs SPY
- Feb 27, 202637w ago 8-K Neutral 4/10 Entry $145.26 to $129.61 Now $92.21 −36.52% ▼ −10.77% −8.79% vs SPY
- Feb 24, 202637w ago 8-K Bullish 8/10 Entry $131.85 to $147.66 Now $92.21 −30.06% ▲ +11.99% +13.09% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers